of the cardiac outflow tract BaltimoreWashington Infant Study Group Epidemiology 1998;9:95–98 64 Gregg NM Congenital cataract following German measles in the mother 1941 Aust N Z J Ophthalmol 1991;19:267–276 65 Pradat P Epidemiology of major congenital heart defects in Sweden, 1981-1986 J Epidemiol Community Health 1992;46:211–215 66 Waller DK, Shaw GM, Rasmussen SA, et al Prepregnancy obesity as a risk factor for structural birth defects Arch Pediatr Adolesc Med 2007;161:745–750 67 Kelly TE, Edwards P, Rein M, Miller JQ, Dreifuss FE Teratogenicity of anticonvulsant drugs II: a prospective study Am J Med Genet 1984;19:435–443 68 Hanson JW Teratogen update: fetal hydantoin effects Teratology 1986;33:349–353 69 Ericson A, Kallen BA Nonsteroidal antiinflammatory drugs in early pregnancy Reprod Toxicol 2001;15:371–375 70 Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA Folic acid antagonists during pregnancy and the risk of birth defects N Engl J Med 2000;343:1608–1614 71 Smithells RW, Newman CG Recognition of thalidomide defects J Med Genet 1992;29:716– 723 72 Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J The teratogenic risk of trimethoprimsulfonamides: a population based case-control study Reprod Toxicol 2001;15:637–646 73 Dai WS, Hsu MA, Itri LM Safety of pregnancy after discontinuation of isotretinoin Arch Dermatol 1989;125:362–365 74 Geiger JM, Baudin M, Saurat JH Teratogenic risk with etretinate and acitretin treatment Dermatology 1994;189:109–116 75 Tikkanen J, Heinonen OP Risk factors for conal malformations of the heart Eur J Epidemiol 1992;8:48–57 76 Shaw GM, Nelson V, Iovannisci DM, Finnell RH, Lammer EJ Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies Am J Epidemiol 2003;157:475–484 77 Tikkanen J, Heinonen OP Risk factors for coarctation of the aorta Teratology 1993;47:565–572 78 Correa-Villasenor A, Ferencz C, Boughman JA, Neill CA Total anomalous pulmonary venous return: familial and environmental factors The Baltimore-Washington Infant Study Group Teratology 1991;44:415–428 79 Correa-Villasenor A, Ferencz C, Neill CA, Wilson PD, Boughman JA Ebstein's malformation of the tricuspid valve: genetic and environmental factors The BaltimoreWashington Infant Study Group Teratology 1994;50:137–147 80 Deleted in review 81 Digilio MC, Marino B, Cicini MP, et al Risk of congenital heart defects in relatives of patients with atrioventricular canal Am J Dis Child 1993;147:1295–1297 82 Emanuel R, Nichols J, Anders JM, Moores EC, Somerville J Atrioventricular defects–a study of 92 families Br Heart J 1968;30:645–653 83 Nora JJ, Nora AH Update on counseling the family with a first-degree relative with a congenital heart defect Am J Med Genet 1988;29:137–142 84 Sanchez-Cascos A The recurrence risk in congenital heart disease Eur J Cardiol 1978;7:197–210 85 Sheffield VC, Pierpont ME, Nishimura D, et al Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis Hum Mol Genet 1997;6:117–121